Types of HPV Vaccine Misinformation Circulating on Twitter (X) That Parents Find Most Concerning: Insights From a Cross-Sectional Survey and Content Analysis

Date
2025-05-12
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
JMIR
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

Background: Parents frequently use social media as a source of information about the human papillomavirus (HPV) vaccine. Our previous work identified that, on Twitter (now X), almost 25% of tweets about the HPV vaccine contain misinformation, and these tweets receive higher audience engagement than accurate tweets. Exposure to misinformation can increase vaccine hesitancy, but the types of misinformation found on social media vary widely, and not all misinformation exposure influences vaccine attitudes and vaccine uptake. Despite the prevalence of misinformation and antivaccine information on social media, little work has assessed parents' assessments of these posts.

Objective: This study examines which types of misinformation on Twitter parents find the most concerning.

Methods: In April 2022, we surveyed 263 US parents of children ages 7-10 years using a Qualtrics survey panel. They viewed a first round of 9 randomly selected tweets from a pool of 126 tweets circulating on Twitter that contained misinformation about the HPV vaccine. Then parents selected up to 3 that they found most concerning. The process was repeated once more with 9 selected from the pool of 117 messages not shown in the first round. Using this information, a concern score for each tweet was calculated based on the number of parents who viewed the tweet and selected it as concerning. In total, 2 researchers independently coded the misinformation tweets to identify rhetorical strategies used and health concerns mentioned. Multiple linear regression tested whether tweet content significantly predicted the concern score of the tweet.

Results: Parental concern about the different misinformation tweets varied widely, with some misinformation being selected as most concerning just 2.8% of the time it was viewed and other misinformation being selected 79.5% of the time it was viewed. Multiple beta regression analyses found that misinformation tweets using negative emotional appeals (b=.79, P<.001), expressing pharmaceutical company skepticism (b=.36, P=.036), invoking governmental authority (b=.44, P=.02), and mentioning hospitalization (b=1.00, P=.003), paralysis (b=.54, P=.02), and infertility (b=.52, P=.04) significantly increased the percent of parents rating the misinformation tweets as most concerning.

Conclusions: Misinformation about HPV vaccination is ubiquitous on social media, and it would be impossible to target and correct all of it. Counter-messaging campaigns and interventions to combat misinformation need to focus on the types of misinformation that concern parents and ultimately may impact vaccine uptake. Results from this study identify the misinformation content that parents find most concerning and provide a useful list of targets for researchers developing interventions to combat misinformation with the goal of increasing HPV vaccine uptake.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Morgan JC, Badlis S, Head KJ, Zimet G, Cappella JN, Kornides ML. Types of HPV Vaccine Misinformation Circulating on Twitter (X) That Parents Find Most Concerning: Insights From a Cross-Sectional Survey and Content Analysis. J Med Internet Res. 2025;27:e54657. Published 2025 May 12. doi:10.2196/54657
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Journal of Medical Internet Research
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}